Clinical Trial Update: Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SAR341402 to NovoLog/NovoRapid in adults with diabetes using insulin glargine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)
• NovoRapid (insulin aspart)
• SAR341402 (SAR341402)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-08-08